Close Menu

WASHINGTON — At the American Clinical Laboratory Association's 2020 Annual Meeting Wednesday, representatives from the US Food and Drug Administration made the case that the agency's response to the SARS-CoV-2 outbreak may be instructive for the future oversight of laboratory-developed tests. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.